Vaccines Birth 1 mo 2 mos 4 mos 6 mos 9 mos 12 mos 15 mos 18 mos 19–23 mos 2-3 yrs 4-6 yrs 7-10 yrs 11-12 yrs 13–15 yrs 16–18 yrs Hepatitis B (HepB) Rotavirus (RV) RV-1 (2-dose series); RV-5 (3-dose series) Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) Tetanus, diphtheria, & acellular pertussis (Tdap: >7 yrs) type b (Hib) Pneumococcal conjugate (PCV13) Pneumococcal polysaccharide (PPSV23) Inactivated Poliovirus (IPV) (<18years) (IIV; LAIV) 2 doses for some : see footnote 8 Measles, mumps, rubella (MMR) Varicella (VAR) Hepatitis A (HepA) Human papillomavirus (HPV2: females only; HPV4: males and females) Meningococcal (Hib-MenCY > 6 weeks; MCV4-D > 9 mos; MCV4-CRM > 2 yrs.) booster 1 dosesee footnote 13 (3-dose series) 2dose series, see footnote 11 2 dose1 dose 2 dose1 dose Annual vaccination (IIV or LAIV) Annual vaccination (IIV only) 4 dose3 dose2 dose1 dose 4 dose3 dose2 dose1 dose 3 or 4 dose, see footnote 5 See footnote 52 dose1 dose (Tdap) 5 dose4 dose3 dose2 dose1 dose See footnote 22 dose1 dose 3 dose2 dose1 dose
Range of recommended ages during which ages for all children
Range of recommended
Range of recommended ages Range of recommended ages for
Not routinely recommended high-risk groups catch-up is encouraged and for certain for catch-up immunization certain high-risk  groups
This schedule includes recommendations in effect as of January 1, 2013. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consult the relevant Advisory Committee on Immunization Practices (ACIP) statement for detailed recommendations, available online at http://www.cdc.gov/vaccines/pubs/acip-list.htm. Clinically significant adverse events that follow vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS) online ( http://www.vaers.hhs.gov ) or by telephone (800-822-7967). Suspected cases of vaccine-preventable diseases should be reported to the state or local health department. Additional information, including precautions and contraindications for vaccination, is available from CDC online (http://www.cdc.gov/vaccines ) or by telephone (800-CDC-INFO [800-232-4636]).
This schedule is approved by the Advisory Committee on Immunization Practices (http://www.cdc.gov/vaccines/acip/index.html), the American Academy of Pediatrics (http://www. aap.org), the American Academy of Family Physicians ( http://www.aafp.org), and the American College of Obstetricians and Gynecologists ( http://www.acog.org).